$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000114420418060568 Filed on November 16, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$412.0K	$453.0K	$148.0K
YoY Change	1273.33%	206.08%	-6.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$27.02M	$5.476M	$4.560M
YoY Change	472.35%	20.09%	-0.44%
% of Gross Profit
Research & Development	$18.15M	$4.296M	$9.721M
YoY Change	48964.86%	-55.81%	-53.92%
% of Gross Profit
Depreciation & Amortization	$228.0K	$341.0K	$41.00K
YoY Change	-24.0%	731.71%	-25.45%
% of Gross Profit
Operating Expenses	$45.17M	$4.296M	$9.721M
YoY Change	121978.38%	-55.81%	-53.92%
Operating Profit		-$9.319M	-$14.13M
YoY Change		-34.06%	-44.61%
Interest Expense	$5.602M	$1.596M	$1.193M
YoY Change	-180.37%	33.78%	72.65%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	-$2.300M
YoY Change		-100.0%	57.53%
Pretax Income	-$35.79M	$12.58M	-$23.27M
YoY Change	32.57%	-154.05%	-20.39%
Income Tax
% Of Pretax Income
Net Earnings	-$35.79M	$12.58M	-$23.27M
YoY Change	32.57%	-154.05%	-20.38%
Net Earnings / Revenue	-8687.86%	2776.6%	-15723.65%
Basic Earnings Per Share		$0.02	-$0.08
Diluted Earnings Per Share	-$81.35K	$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	513.4M shares	461.0M shares	281.5M shares
Diluted Shares Outstanding		516.3M shares	281.5M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.22M	$248.0K	$1.050M
YoY Change	18420.0%	-76.38%	31.25%
Cash & Equivalents	$22.22M	$248.0K	$1.051M
Short-Term Investments
Other Short-Term Assets	$1.574M	$870.0K	$1.080M
YoY Change	22.02%	-19.44%	-27.03%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$23.80M	$1.118M	$2.130M
YoY Change	1597.43%	-47.51%	-6.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$108.0K	$45.15M	$47.51M
YoY Change	-99.77%	-4.97%	2.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$761.0K	$67.00K	$110.0K
YoY Change	4376.47%	-39.09%	-8.33%
Total Long-Term Assets	$869.0K	$45.22M	$47.62M
YoY Change	-98.17%	-5.05%	2.04%
TOTAL ASSETS
Total Short-Term Assets	$23.80M	$1.118M	$2.130M
Total Long-Term Assets	$869.0K	$45.22M	$47.62M
Total Assets	$24.67M	$46.33M	$49.75M
YoY Change	-49.56%	-6.87%	1.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.09M	$25.71M	$44.95M
YoY Change	9.21%	-42.81%	78.51%
Accrued Expenses		$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$65.00K	$0.00
YoY Change
Long-Term Debt Due	$14.81M	$0.00	$11.54M
YoY Change	-24.43%	-100.0%	-45.28%
Total Short-Term Liabilities	$69.84M	$77.28M	$81.13M
YoY Change	-20.35%	-4.75%	50.35%
LONG-TERM LIABILITIES
Long-Term Debt	$1.986M	$16.20M	$11.45M
YoY Change	-76.69%	41.46%
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$1.986M	$16.20M	$11.45M
YoY Change	-76.68%	41.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$69.84M	$77.28M	$81.13M
Total Long-Term Liabilities	$1.986M	$16.20M	$11.45M
Total Liabilities	$71.83M	$93.47M	$92.58M
YoY Change	-25.34%	0.96%	71.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$824.4M
YoY Change	4.54%
Common Stock	$776.3M	$771.2M
YoY Change	7.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$48.13M	-$47.14M	-$42.83M
YoY Change
Total Liabilities & Shareholders Equity	$24.67M	$46.33M	$49.75M
YoY Change	-49.56%	-6.87%	1.66%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$35.79M	$12.58M	-$23.27M
YoY Change	32.57%	-154.05%	-20.38%
Depreciation, Depletion And Amortization	$228.0K	$341.0K	$41.00K
YoY Change	-24.0%	731.71%	-25.45%
Cash From Operating Activities	-$14.18M	-$4.048M	-$5.720M
YoY Change	-4.2%	-29.23%	-41.39%
INVESTING ACTIVITIES
Capital Expenditures	-$193.0K	$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$45.60M	$0.00	$0.00
YoY Change
Cash From Investing Activities	$45.40M	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.82M	2.062M	8.100M
YoY Change	-175.72%	-74.54%	5.47%
NET CHANGE
Cash From Operating Activities	-14.18M	-4.048M	-5.720M
Cash From Investing Activities	45.40M	0.000	0.000
Cash From Financing Activities	-10.82M	2.062M	8.100M
Net Change In Cash	20.40M	-1.986M	2.380M
YoY Change	-4100.59%	-183.45%	-193.33%
FREE CASH FLOW
Cash From Operating Activities	-$14.18M	-$4.048M	-$5.720M
Capital Expenditures	-$193.0K	$0.00	$0.00
Free Cash Flow	-$13.98M	-$4.048M	-$5.720M
YoY Change	-5.51%	-29.23%	-38.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	NORTHWEST BIOTHERAPEUTICS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001072379
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Trading Symbol TradingSymbol	NWBO
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	513359936	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	870000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1285000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	1118000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	1402000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45149000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47488000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17000	USD
CY2018Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	45216000	USD
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	47505000	USD
CY2018Q3	us-gaap	Assets Assets	46334000	USD
CY2017Q4	us-gaap	Assets Assets	48907000	USD
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	21958000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13015000	USD
CY2018Q3	nwbo	Accounts Payable And Accrued Liabilities Related Parties Current AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent	3750000	USD
CY2017Q4	nwbo	Accounts Payable And Accrued Liabilities Related Parties Current AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent	5385000	USD
CY2018Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	135000	USD
CY2017Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	135000	USD
CY2018Q3	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	5400000	USD
CY2017Q4	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	0	USD
CY2018Q3	us-gaap	Notes Payable Current NotesPayableCurrent	4130000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7122000	USD
CY2018Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	434000	USD
CY2017Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1121000	USD
CY2018Q3	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	855000	USD
CY2017Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	3308000	USD
CY2018Q3	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2017Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2018Q3	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	138000	USD
CY2017Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	0	USD
CY2018Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	29552000	USD
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	40171000	USD
CY2018Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	4724000	USD
CY2017Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	11226000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	77276000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87683000	USD
CY2018Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5188000	USD
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	6010000	USD
CY2018Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	4519000	USD
CY2017Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2507000	USD
CY2018Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	6490000	USD
CY2017Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0	USD
CY2018Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16197000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8517000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	93473000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	96200000	USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	510000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	329000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	770739000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	721554000	USD
CY2018Q3	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	818763000	USD
CY2017Q4	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	788619000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	385000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-597000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	-47139000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-67333000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46334000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48907000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	453000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	148000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	863000	USD
CY2018Q3	nwbo	Deemed Dividend On Convertible Preferred Stock DeemedDividendOnConvertiblePreferredStock	4175000	USD
CY2017Q3	nwbo	Deemed Dividend On Convertible Preferred Stock DeemedDividendOnConvertiblePreferredStock	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4104000	USD
	nwbo	Deemed Dividend On Convertible Preferred Stock DeemedDividendOnConvertiblePreferredStock	17765000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2963000	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-229000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1975000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-830000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10517000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	1596000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	1193000	USD
	us-gaap	Interest Expense InterestExpense	8222000	USD
	us-gaap	Interest Expense InterestExpense	3695000	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-636000	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	1260000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1823000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	304000	USD
CY2018Q3	us-gaap	Revenues Revenues	453000	USD
CY2017Q3	us-gaap	Revenues Revenues	148000	USD
	us-gaap	Revenues Revenues	863000	USD
	us-gaap	Revenues Revenues	304000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4296000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9721000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14311000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20222000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3531000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2965000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20985000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9254000	USD
CY2018Q3	us-gaap	Legal Fees LegalFees	1945000	USD
CY2017Q3	us-gaap	Legal Fees LegalFees	1595000	USD
	us-gaap	Legal Fees LegalFees	4056000	USD
	us-gaap	Legal Fees LegalFees	7530000	USD
CY2018Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9772000	USD
CY2017Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14281000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	39352000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	37006000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9319000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14133000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38489000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36702000	USD
CY2018Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	24358000	USD
CY2017Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4933000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	19220000	USD
	nwbo	Deemed Dividend On Convertible Preferred Stock DeemedDividendOnConvertiblePreferredStock	0	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8403000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23271000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47909000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46144000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	12578000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-23271000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46144000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-301000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	561000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-982000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2201000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12879000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23832000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29162000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48345000	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	700000	USD
	nwbo	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	18929000	USD
	nwbo	Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStock	-10892000	USD
	nwbo	Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series B Convertible Preferred Stock AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesBConvertiblePreferredStock	2086000	USD
	nwbo	Adjustments To Additional Paid In Capitaldeemed Dividends Related To Accretion Of Redemption Value Of Series B Convertible Stock AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToAccretionOfRedemptionValueOfSeriesBConvertibleStock	2086000	USD
	nwbo	Stock Issued During Period Value Conversion Of Convertible Preferred Stock One StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockOne	19697000	USD
	nwbo	Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock One AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStockOne	4787000	USD
	nwbo	Value Of Warrants Exercised For Cash ValueOfWarrantsExercisedForCash	2119000	USD
	nwbo	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification	2177000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2453000	USD
	nwbo	Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest	5522000	USD
	nwbo	Shareholders Equity Reclass Between Accrued Interest And Subscription Receivable ShareholdersEquityReclassBetweenAccruedInterestAndSubscriptionReceivable	9000	USD
	nwbo	Shareholders Equity Proceeds From Investor To Offset Subscription Receivable ShareholdersEquityProceedsFromInvestorToOffsetSubscriptionReceivable	100000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13329000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-30144000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1063000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	141000	USD
	nwbo	Amortization Of Debt Discount AmortizationOfDebtDiscount	5882000	USD
	nwbo	Amortization Of Debt Discount AmortizationOfDebtDiscount	1158000	USD
	nwbo	Amortization Of Debt Premium AmortizationOfDebtPremium	319000	USD
	nwbo	Amortization Of Debt Premium AmortizationOfDebtPremium	-407000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	19220000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2963000	USD
	nwbo	Stock Based Compensation Related To Warrants Modification StockBasedCompensationRelatedToWarrantsModification	141000	USD
	nwbo	Stock Based Compensation Related To Warrants Modification StockBasedCompensationRelatedToWarrantsModification	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	13329000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	729000	USD
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1706000	USD
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	11836000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-428000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	72000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	55000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	-38000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4493000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4368000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	3164000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	8273000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20408000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21701000	USD
	nwbo	Refund Of Leashold Improvement Related To Uk Construction RefundOfLeasholdImprovementRelatedToUkConstruction	0	USD
	nwbo	Refund Of Leashold Improvement Related To Uk Construction RefundOfLeasholdImprovementRelatedToUkConstruction	-220000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	14000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	206000	USD
	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	1000000	USD
	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	8653000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1616000	USD
	nwbo	Proceeds From Subscription Receivable ProceedsFromSubscriptionReceivable	138000	USD
	nwbo	Proceeds From Subscription Receivable ProceedsFromSubscriptionReceivable	2550000	USD
	nwbo	Proceeds From Investors ProceedsFromInvestors	100000	USD
	nwbo	Proceeds From Investors ProceedsFromInvestors	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2119000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2805000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5701000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4864000	USD
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	95000	USD
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	2805000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1604000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5400000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2200000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	782000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1644000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3258000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18692000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19995000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1847000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4320000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	131000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5820000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6871000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1051000	USD
	us-gaap	Interest Paid Net InterestPaidNet	27000	USD
	us-gaap	Interest Paid Net InterestPaidNet	47000	USD
	nwbo	Proceeds From Issuance Of Common Stock And Debt ProceedsFromIssuanceOfCommonStockAndDebt	21700000	USD
CY2018Q3	nwbo	Current Assets Less Payables CurrentAssetsLessPayables	76200000	USD
CY2018Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	3800000	USD
CY2018Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1690000	USD
CY2018Q3	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	855000	USD
CY2018Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	32097000	USD
CY2017Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2608000	USD
CY2017Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	3308000	USD
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	46087000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	46087000	USD
	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Warrant Granted FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisWarrantGranted	9509000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	2177000	USD
	nwbo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Related To Conversion Of Sharesettled Debt FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlementsRelatedToConversionOfSharesettledDebt	2453000	USD
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-19220000	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	32097000	USD
CY2018Q3	us-gaap	Depreciation Depreciation	341000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	41000	USD
	us-gaap	Depreciation Depreciation	1063000	USD
	us-gaap	Depreciation Depreciation	141000	USD
CY2018Q3	nwbo	Share Based Compensation Arrangement By Share Based Payment Award Options Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVested	0.5	pure
CY2018Q3	nwbo	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVest	0.5	pure
CY2018Q3	nwbo	Additional Stock Based Compensation Expense AdditionalStockBasedCompensationExpense	1000000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12656000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.56
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100090000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.23
	nwbo	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P9Y7M6D
CY2018Q3	nwbo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	12587000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100159000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M6D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	78267000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y6M
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.96	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.03	pure
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1455000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	119000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13293000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	492000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	16300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	300000	USD
	nwbo	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition2 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition2	P1Y6M
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2018Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	32746000	USD
CY2018Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2561000	USD
CY2018Q3	nwbo	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	1690000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	31875000	USD
CY2017Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	31375000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2554000	USD
CY2017Q4	nwbo	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	2608000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	31429000	USD
CY2018Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.1	pure
CY2018Q2	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	4200000	USD
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	100000	USD
CY2018Q1	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	30000	USD
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1200000	USD
CY2018Q3	us-gaap	Interest Expense Other InterestExpenseOther	2000	USD
CY2017Q3	us-gaap	Interest Expense Other InterestExpenseOther	5000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	5000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	10000	USD
CY2018Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1596000	USD
CY2017Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1193000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	8222000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3695000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	522817000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	230322000	shares
CY2018Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1408000	USD
CY2017Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	7847000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	6111000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	13035000	USD
CY2018Q3	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	11785000	USD
CY2017Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	5203000	USD
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.30
CY2018Q3	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	4200000	USD
CY2018Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	69000	USD
CY2017Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	400000	USD
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q2	nwbo	Percentage Of Voting Interest Favouring Common Stock Increase PercentageOfVotingInterestFavouringCommonStockIncrease	0.87	pure
CY2018Q2	nwbo	Percentage Of Voting Interest Favouring Preferred Stock Increase PercentageOfVotingInterestFavouringPreferredStockIncrease	0.86	pure
CY2018Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	4400000	USD
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	22300000	shares
CY2018Q3	nwbo	Shares Issued During Period Shares Upon Exercise Of Warrants SharesIssuedDuringPeriodSharesUponExerciseOfWarrants	9000000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2100000	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	320406000	shares
CY2017Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0.50
CY2017	nwbo	Class Of Warrant Or Right Oustanding Remaining Contractual Term ClassOfWarrantOrRightOustandingRemainingContractualTerm	P2Y7M13D
	nwbo	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	69134000	shares
	nwbo	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	0.50
	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	8957000	shares
	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	0.23
	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	11652000	shares
	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	1.22
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	368931000	shares
CY2018Q3	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0.29
	nwbo	Class Of Warrant Or Right Oustanding Remaining Contractual Term ClassOfWarrantOrRightOustandingRemainingContractualTerm	P2Y2M16D
CY2017Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	496000	USD
CY2018Q3	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	10000	USD
CY2017Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	0	USD
CY2018Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	510100000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	328900000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	510100000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	328900000	shares
CY2018Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2017Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	2297000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	2297000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	461040000	shares
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	281486000	shares
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	414426000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	217587000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	516300000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	281486000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	414426000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	217587000	shares
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	982000	USD
	nwbo	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	0	USD
	nwbo	Deemed Dividends On Conversion Of Series Convertible Preferred Stock To Common Stock DeemedDividendsOnConversionOfSeriesConvertiblePreferredStockToCommonStock	10892000	USD
	nwbo	Deemed Dividends On Conversion Of Series Convertible Preferred Stock To Common Stock DeemedDividendsOnConversionOfSeriesConvertiblePreferredStockToCommonStock	0	USD
	nwbo	Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series B Convertible Preferred Stock AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesBConvertiblePreferredStock	0	USD
	nwbo	Adjustments To Additional Paid In Capitaldeemed Dividends Related To Accretion Of Redemption Value Of Series B Convertible Stock AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToAccretionOfRedemptionValueOfSeriesBConvertibleStock	0	USD
	nwbo	Stock Issued During Period Value Conversion Of Convertible Preferred Stock One StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockOne	0	USD
	nwbo	Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock One AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStockOne	0	USD
	nwbo	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification	2117000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1187000	USD
	nwbo	Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived	4692000	USD
	nwbo	Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived	10975000	USD
	us-gaap	Notes Reduction NotesReduction	0	USD
	us-gaap	Notes Reduction NotesReduction	3750000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	1826000	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
	nwbo	Debt Conversion Converted Instrument Associate Warrants DebtConversionConvertedInstrumentAssociateWarrants	4217000	USD
	nwbo	Debt Conversion Converted Instrument Associate Warrants DebtConversionConvertedInstrumentAssociateWarrants	0	USD
	nwbo	Warrants Issued Associated With Convertible Notes Payable To Related Party WarrantsIssuedAssociatedWithConvertibleNotesPayableToRelatedParty	67000	USD
	nwbo	Warrants Issued Associated With Convertible Notes Payable To Related Party WarrantsIssuedAssociatedWithConvertibleNotesPayableToRelatedParty	139000	USD
	nwbo	Reclassification Of Accrued Interst To Subscription Receivable ReclassificationOfAccruedInterstToSubscriptionReceivable	9000	USD
	nwbo	Reclassification Of Accrued Interst To Subscription Receivable ReclassificationOfAccruedInterstToSubscriptionReceivable	0	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	2297000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	0	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	3054000	USD
	nwbo	Stock Issued During Period Value For Warrant Cashless Exercise StockIssuedDuringPeriodValueForWarrantCashlessExercise	0	USD
	nwbo	Stock Issued During Period Value For Warrant Cashless Exercise StockIssuedDuringPeriodValueForWarrantCashlessExercise	7000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	212000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	218000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 1.04in; margin-right: 0px; background: none;"> </div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply, and the fair value of environmental remediation liabilities.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3	nwbo	Bifurcated Embedded Derivative Fair Value Of Embedded Derivative Liability BifurcatedEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	351000	USD
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	the Board also approved extension of the term of options that were granted to Dr. Alton Boyton and Dr. Marnix Bosch on June 13, 2017, from 5 years to 10 years
CY2018Q2	nwbo	Warrants Exercise Number WarrantsExerciseNumber	23500000	shares
CY2018Q2	nwbo	Warrants Exercise Value WarrantsExerciseValue	11700000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	935000	USD
CY2018Q3	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	525000	USD
CY2018Q3	us-gaap	Notes Payable NotesPayable	135000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	135000	USD
CY2018Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5400000	USD
CY2018Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2617000	USD
CY2017Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11020000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23271000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-47909000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-46144000	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1533000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	41960000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	11767000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	65000	USD
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	10000000	shares
CY2018Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	100000000	shares
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	300000	USD
CY2018Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2018Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2018Q3	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	1000000	USD

Files In Submission

Name	View Source	Status
0001144204-18-060568-index-headers.html	Edgar Link	pending
0001144204-18-060568-index.html	Edgar Link	pending
0001144204-18-060568.txt	Edgar Link	pending
0001144204-18-060568-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nwbo-20180930.xml	Edgar Link	completed
nwbo-20180930.xsd	Edgar Link	pending
nwbo-20180930_cal.xml	Edgar Link	unprocessable
nwbo-20180930_def.xml	Edgar Link	unprocessable
nwbo-20180930_lab.xml	Edgar Link	unprocessable
nwbo-20180930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv507283_10q.htm	Edgar Link	pending
tv507283_ex31-1.htm	Edgar Link	pending
tv507283_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2018 Q4 Form 10-Q Financial Statement

#000114420418060568 Filed on November 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2018 Q4 Form 10-Q Financial Statement

#000114420418060568 Filed on November 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo